{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:22Z","timestamp":1792510942755,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12264-025-01398-0","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:04:08Z","timestamp":1747242248000},"page":"1229-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting 5-HT to Alleviate Dose-Limiting Neurotoxicity in Nab-Paclitaxel-Based Chemotherapy"],"prefix":"10.1007","volume":"41","author":[{"given":"Shuangyue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronggui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7587-312X","authenticated-orcid":false,"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"1398_CR1","volume":"545","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li S, Zhang J, Zhang W, Jiang J, Wu H. Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING\/MAVS signaling pathway. Cancer Lett 2022, 545: 215829.","journal-title":"Cancer Lett"},{"key":"1398_CR2","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/annonc\/mds203","volume":"23","author":"LC Hanker","year":"2012","unstructured":"Hanker LC, Loibl S, Burchardi N, Pfisterer J, Meier W, Pujade-Lauraine E, et al. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane\/platinum-based therapy. Ann Oncol 2012, 23: 2605\u20132612.","journal-title":"Ann Oncol"},{"key":"1398_CR3","volume":"5","author":"H Mo","year":"2022","unstructured":"Mo H, Yan X, Zhao F, Teng Y, Sun X, Lv Z, et al. Association of taxane type with patient-reported chemotherapy-induced peripheral neuropathy among patients with breast cancer. JAMA Netw Open 2022, 5: e2239788.","journal-title":"JAMA Netw Open"},{"key":"1398_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","volume":"82","author":"AA Argyriou","year":"2012","unstructured":"Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Crit Rev Oncol Hematol 2012, 82: 51\u201377.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1398_CR5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2014.09.016","volume":"135","author":"NPM Ezendam","year":"2014","unstructured":"Ezendam NPM, Pijlman B, Bhugwandass C, Pruijt JFM, Mols F, Vos MC, et al. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry. Gynecol Oncol 2014, 135: 510\u2013517.","journal-title":"Gynecol Oncol"},{"key":"1398_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","volume":"46","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, et al. Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools. Eur J Cancer 2010, 46: 479\u2013494.","journal-title":"Eur J Cancer"},{"key":"1398_CR7","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1007\/s00520-016-3373-1","volume":"24","author":"DR Pachman","year":"2016","unstructured":"Pachman DR, Qin R, Seisler D, Smith EM, Kaggal S, Novotny P, et al. Comparison of oxaliplatin and paclitaxel-induced neuropathy (alliance A151505). Support Care Cancer 2016, 24: 5059\u20135068.","journal-title":"Support Care Cancer"},{"key":"1398_CR8","doi-asserted-by":"crossref","unstructured":"Addington J, Freimer M. Chemotherapy-induced peripheral neuropathy: An update on the current understanding. F1000Res 2016, 5: F1000FacultyRev\u2013F1000Faculty1466.","DOI":"10.12688\/f1000research.8053.1"},{"key":"1398_CR9","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00520-019-05063-x","volume":"28","author":"JS Gewandter","year":"2020","unstructured":"Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J, et al. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: An NIH Collaboratory study of claims data. Support Care Cancer 2020, 28: 2553\u20132562.","journal-title":"Support Care Cancer"},{"key":"1398_CR10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. Eur J Cancer 2005, 41: 1135\u20131139.","journal-title":"Eur J Cancer"},{"key":"1398_CR11","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1007\/s00520-019-04781-6","volume":"27","author":"AC Tan","year":"2019","unstructured":"Tan AC, Matt McCrary J, Park SB, Trinh T, Goldstein D. Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade. Support Care Cancer 2019, 27: 4771\u20134777.","journal-title":"Support Care Cancer"},{"key":"1398_CR12","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s00520-017-3772-y","volume":"25","author":"J Matt McCrary","year":"2017","unstructured":"Matt McCrary J, Goldstein D, Boyle F, Cox K, Grimison P, Kiernan MC, et al. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): A systematic review and Delphi survey. Support Care Cancer 2017, 25: 3485\u20133493.","journal-title":"Support Care Cancer"},{"key":"1398_CR13","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Shan H, Yang W, Zhang J, Dai H, Ye Z. Vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: A meta-analysis. Front Pharmacol 2021, 12: 684550.","journal-title":"Front Pharmacol"},{"key":"1398_CR14","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 2020, 38: 3325\u20133348.","journal-title":"J Clin Oncol"},{"key":"1398_CR15","first-page":"571","volume":"21","author":"S Hou","year":"2018","unstructured":"Hou S, Huh B, Kim HK, Kim KH, Abdi S. Treatment of chemotherapy-induced peripheral neuropathy: Systematic review and recommendations. Pain Physician 2018, 21: 571\u2013592.","journal-title":"Pain Physician"},{"key":"1398_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.expneurol.2016.11.015","volume":"288","author":"EL Gornstein","year":"2017","unstructured":"Gornstein EL, Schwarz TL. Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects. Exp Neurol 2017, 288: 153\u2013166.","journal-title":"Exp Neurol"},{"key":"1398_CR17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pain.2011.12.011","volume":"153","author":"WH Xiao","year":"2012","unstructured":"Xiao WH, Bennett GJ. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain 2012, 153: 704\u2013709.","journal-title":"Pain"},{"key":"1398_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","volume":"2","author":"A Areti","year":"2014","unstructured":"Areti A, Yerra VG, Naidu V, Kumar A. Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy. Redox Biol 2014, 2: 289\u2013295.","journal-title":"Redox Biol"},{"key":"1398_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","volume":"208","author":"AC Bulua","year":"2011","unstructured":"Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011, 208: 519\u2013533.","journal-title":"J Exp Med"},{"key":"1398_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12264-021-00797-3","volume":"38","author":"Z Tan","year":"2022","unstructured":"Tan Z, Lin ZJ, Wu LJ, Zhou LJ. The macrophage IL-23\/IL-17A pathway: A new neuro-immune mechanism in female mechanical pain. Neurosci Bull 2022, 38: 453\u2013455.","journal-title":"Neurosci Bull"},{"key":"1398_CR21","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/srep06370","volume":"4","author":"W Boehmerle","year":"2014","unstructured":"Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M. Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice. Sci Rep 2014, 4: 6370.","journal-title":"Sci Rep"},{"key":"1398_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","volume":"76","author":"E Gornstein","year":"2014","unstructured":"Gornstein E, Schwarz TL. The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions. Neuropharmacology 2014, 76: 175\u2013183.","journal-title":"Neuropharmacology"},{"key":"1398_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pain.2010.10.030","volume":"152","author":"J Boyette-Davis","year":"2011","unstructured":"Boyette-Davis J, Xin W, Zhang H, Dougherty PM. Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain 2011, 152: 308\u2013313.","journal-title":"Pain"},{"key":"1398_CR24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s12264-022-00876-z","volume":"38","author":"G Yang","year":"2022","unstructured":"Yang G, Geng H, Hu C. Targeting 5-HT as a potential treatment for social deficits in autism. Neurosci Bull 2022, 38: 1263\u20131266.","journal-title":"Neurosci Bull"},{"key":"1398_CR25","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2147\/JPR.S275254","volume":"13","author":"X Liu","year":"2020","unstructured":"Liu X, Wang G, Ai G, Xu X, Niu X, Zhang M. Selective ablation of descending serotonin from the rostral ventromedial medulla unmasks its pro-nociceptive role in chemotherapy-induced painful neuropathy. J Pain Res 2020, 13: 3081\u20133094.","journal-title":"J Pain Res"},{"key":"1398_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/MN:30:2:117","volume":"30","author":"C Sommer","year":"2004","unstructured":"Sommer C. Serotonin in pain and analgesia: Actions in the periphery. Mol Neurobiol 2004, 30: 117\u2013125.","journal-title":"Mol Neurobiol"},{"key":"1398_CR27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2021.12.014","volume":"527","author":"F You","year":"2022","unstructured":"You F, Zhang C, Liu X, Ji D, Zhang T, Yu R, et al. Drug repositioning: Using psychotropic drugs for the treatment of glioma. Cancer Lett 2022, 527: 140\u2013149.","journal-title":"Cancer Lett"},{"key":"1398_CR28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10787-021-00849-0","volume":"29","author":"MH Mahnashi","year":"2021","unstructured":"Mahnashi MH, Jabbar Z, Alamgeer Irfan HM, Asim MH, Akram M, et al. Venlafaxine demonstrated anti-arthritic activity possibly through down regulation of TNF-\u03b1, IL-6, IL-1\u03b2, and COX-2. Inflammopharmacology 2021, 29: 1413\u20131425.","journal-title":"Inflammopharmacology"},{"key":"1398_CR29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s12264-023-01061-6","volume":"39","author":"W Guan","year":"2023","unstructured":"Guan W, Li B. Diverse roles of serotonergic projections to the basolateral amygdala. Neurosci Bull 2023, 39: 1463\u20131465.","journal-title":"Neurosci Bull"},{"key":"1398_CR30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1993.tb03217.x","volume":"60","author":"S Hjorth","year":"1993","unstructured":"Hjorth S. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. J Neurochem 1993, 60: 776\u2013779.","journal-title":"J Neurochem"},{"key":"1398_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(96)00779-0","volume":"316","author":"S Hjorth","year":"1996","unstructured":"Hjorth S, Bengtsson HJ, Milano S. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. Eur J Pharmacol 1996, 316: 43\u201347.","journal-title":"Eur J Pharmacol"},{"key":"1398_CR32","doi-asserted-by":"crossref","unstructured":"Gallagher HC, Gallagher RM, Butler M, Buggy DJ, Henman MC. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev 2015, 2015: CD011091.","DOI":"10.1002\/14651858.CD011091"},{"key":"1398_CR33","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00520-015-3009-x","volume":"24","author":"T Kus","year":"2016","unstructured":"Kus T, Aktas G, Alpak G, Kalender ME, Sevinc A, Kul S, et al. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: A single-center retrospective case-control study. Support Care Cancer 2016, 24: 2085\u20132091.","journal-title":"Support Care Cancer"},{"key":"1398_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchromb.2019.02.021","volume":"1112","author":"LS Wang","year":"2019","unstructured":"Wang LS, Zhang MD, Tao X, Zhou YF, Liu XM, Pan RL, et al. LC-MS\/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice. J Chromatogr B Analyt Technol Biomed Life Sci 2019, 1112: 24\u201332.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1398_CR35","volume":"33","author":"YJ Wang","year":"2020","unstructured":"Wang YJ, Liu MG, Wang JH, Cao W, Wu C, Wang ZY, et al. Restoration of cingulate long-term depression by enhancing non-apoptotic caspase 3 alleviates peripheral pain hypersensitivity. Cell Rep 2020, 33: 108369.","journal-title":"Cell Rep"},{"key":"1398_CR36","doi-asserted-by":"crossref","first-page":"155932582211198","DOI":"10.1177\/15593258221119877","volume":"20","author":"D Srebro","year":"2022","unstructured":"Srebro D, Rajkovi\u0107 K, Do\u017ei\u0107 B, Vujovi\u0107 KS, Brki\u0107 BM, Mili\u0107 P, et al. Investigation of the antinociceptive activity of the hydroethanolic extract of Junglas nigra leaf by the tail-immersion and formalin pain tests in rats. Dose Response 2022, 20: 15593258221119876.","journal-title":"Dose Response"},{"key":"1398_CR37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/ijms22020674","volume":"22","author":"\u00d3D Garc\u00eda-Garc\u00eda","year":"2021","unstructured":"Garc\u00eda-Garc\u00eda \u00d3D, El Soury M, Gonz\u00e1lez-Quevedo D, S\u00e1nchez-Porras D, Chato-Astrain J, Campos F, et al. Histological, biomechanical, and biological properties of genipin-crosslinked decellularized peripheral nerves. Int J Mol Sci 2021, 22: 674.","journal-title":"Int J Mol Sci"},{"key":"1398_CR38","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3390\/ijms22052389","volume":"22","author":"M El Soury","year":"2021","unstructured":"El Soury M, Garc\u00eda-Garc\u00eda \u00d3D, Moretti M, Perroteau I, Raimondo S, Lovati AB, et al. Comparison of decellularization protocols to generate peripheral nerve grafts: A study on rat sciatic nerves. Int J Mol Sci 2021, 22: 2389.","journal-title":"Int J Mol Sci"},{"key":"1398_CR39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12888-021-03253-8","volume":"21","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang X, Feng L, Xiao L, Yang R, Zhu X, et al. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder An 8-week, randomized, single-blind, active-controlled study. BMC Psychiatry 2021, 21: 260.","journal-title":"BMC Psychiatry"},{"key":"1398_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cell.2020.07.015","volume":"182","author":"JD Matute","year":"2020","unstructured":"Matute JD, Duan J, Blumberg RS. Microbial RNAs pressure Piezo1 to respond. Cell 2020, 182: 542\u2013544.","journal-title":"Cell"},{"key":"1398_CR41","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1073\/pnas.0805323106","volume":"106","author":"K Nozawa","year":"2009","unstructured":"Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A 2009, 106: 3408\u20133413.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1398_CR42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","volume":"6","author":"TA Furukawa","year":"2019","unstructured":"Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: A systematic review and dose-response meta-analysis. Lancet Psychiatry 2019, 6: 601\u2013609.","journal-title":"Lancet Psychiatry"},{"key":"1398_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215591","volume":"537","author":"S Modi","year":"2022","unstructured":"Modi S, Giri B, Gupta VK, Lavania S, Sethi V, Sharma NS, et al. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Cancer Lett 2022, 537: 215591.","journal-title":"Cancer Lett"},{"key":"1398_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215863","volume":"546","author":"Z Tian","year":"2022","unstructured":"Tian Z, Ou G, Su M, Li R, Pan L, Lin X, et al. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Cancer Lett 2022, 546: 215863.","journal-title":"Cancer Lett"},{"key":"1398_CR45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1089\/ten.tea.2014.0416","volume":"21","author":"L Huang","year":"2015","unstructured":"Huang L, Quan X, Liu Z, Ma T, Wu Y, Ge J, et al. C-Jun gene-modified Schwann cells: Upregulating multiple neurotrophic factors and promoting neurite outgrowth. Tissue Eng Part A 2015, 21: 1409\u20131421.","journal-title":"Tissue Eng Part A"},{"key":"1398_CR46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12264-022-00967-x","volume":"39","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yu Z, Xiao B. Coordinated regulation of myelination by growth factor and amino-acid signaling pathways. Neurosci Bull 2023, 39: 453\u2013465.","journal-title":"Neurosci Bull"},{"key":"1398_CR47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1098-1136(199605)17:1<15::AID-GLIA2>3.0.CO;2-6","volume":"17","author":"EJ Yoder","year":"1996","unstructured":"Yoder EJ, Tamir H, Ellisman MH. 5-Hydroxytryptamine2A receptors on cultured rat Schwann cells. Glia 1996, 17: 15\u201327.","journal-title":"Glia"},{"key":"1398_CR48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jnc.12988","volume":"133","author":"LW Fan","year":"2015","unstructured":"Fan LW, Bhatt A, Tien LT, Zheng B, Simpson KL, Lin RCS, et al. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem 2015, 133: 532\u2013543.","journal-title":"J Neurochem"},{"key":"1398_CR49","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1007\/s12035-019-1616-0","volume":"56","author":"E Kim","year":"2019","unstructured":"Kim E, Hwang SH, Kim HK, Abdi S, Kim HK. Losartan, an angiotensin II type 1 receptor antagonist, alleviates mechanical hyperalgesia in a rat model of chemotherapy-induced neuropathic pain by inhibiting inflammatory cytokines in the dorsal root Ganglia. Mol Neurobiol 2019, 56: 7408\u20137419.","journal-title":"Mol Neurobiol"},{"key":"1398_CR50","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/ijms20071652","volume":"20","author":"D Li","year":"2019","unstructured":"Li D, Lee JH, Choi CW, Kim J, Kim SK, Kim W. The analgesic effect of venlafaxine and its mechanism on oxaliplatin-induced neuropathic pain in mice. Int J Mol Sci 2019, 20: 1652.","journal-title":"Int J Mol Sci"},{"key":"1398_CR51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12264-023-01039-4","volume":"39","author":"C He","year":"2023","unstructured":"He C, Duan S. Novel insight into glial biology and diseases. Neurosci Bull 2023, 39: 365\u2013367.","journal-title":"Neurosci Bull"},{"key":"1398_CR52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12264-022-00917-7","volume":"39","author":"L Yang","year":"2023","unstructured":"Yang L, Zhang D, Zhang Q. Astrocyte-mediated myelin phagocytosis in ischemia. Neurosci Bull 2023, 39: 167\u2013169.","journal-title":"Neurosci Bull"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01398-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:34:41Z","timestamp":1751531681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01398-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01398-0","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}